Skip to content

Category: Biotechnology

Wilderlands protects 100,000 square metres of vulnerable Australian habitat through biodiversity credits.

By API User

Wilderlands have reached a major milestone becoming the world’s fastest voluntary biodiversity credit developer to retire over 100,000 units which will protect over 10 hectares of vulnerable Australian habitat, forever.   The announcement was made at an event this week with over 100 leaders gathering at the University of Melbourne’s innovation precinct Melbourne Connect for … Continued

Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects.

By API User

VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) — The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most common form of precancer, with over 40 million Americans a year developing this condition. Treating AKs before the cells become cancerous and spread to other parts of the body is crucial. For those patients with multiple AKs, common treatment options are … Continued

Seaport Therapeutics receives $100 million in funding to maximise Monash invention

By API User

Seaport Therapeutics, a clinical-stage biopharmaceutical company based around a unique drug delivery platform originally developed by Monash University researchers, has announced the closing of a US$100 million oversubscribed Series A financing round. The round was co-led by ARCH Venture Partners and Sofinnova Investments along with Third Rock Ventures and Seaport founder PureTech Health.    Using … Continued

UNSW and Mid North Coast Local Health District to boost research and students in rural communities

By API User

The strategic partnership will place UNSW students at local hospitals and streamline research collaboration opportunities.   UNSW Sydney has signed an historic three-year Memorandum of Understanding (MoU) with the Mid North Coast Local Health District (MNCLHD), to help identify potential collaborative research opportunities and place undergraduate students in local rural health facilities.   UNSW Vice-Chancellor … Continued

CLEO Appoints CRO to Manage U.S. Ovarian Cancer Clinical Trials

By API User

  Highlights CLEO has appointed U.S.-based Lindus Health to manage U.S. clinical trials for its revolutionary ovarian cancer blood test Lindus Health is a leader in clinical trial management for the med-tech sector, with a strong record of timely and successful trial execution CLEO’s U.S. study will prospectively recruit up to 500 patients commencing next … Continued

Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization

By API User

Clairvoyant on target for potential commercialization of psilocybin treatment in 2025 VANCOUVER, BC / ACCESSWIRE / April 3, 2024 / Clairvoyant Therapeutics Inc. (www.clairvoyantrx.com), the private clinical-stage pharmaceutical company developing psilocybin treatment for alcohol use disorder (AUD), today announced that it is on target to potentially become the first in the world to commercialize clinically … Continued

Plants to be grown on the moon when humans return

By API User

NASA has announced that when humans take their first steps back on the moon after 50 years during the Artemis III mission, astronauts will cultivate and return lunar-grown plants to Earth for the first time. Known as Lunar Effects on Agricultural Flora (LEAF), the project will collect plant growth and development data that will help … Continued